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        Timely coordination of cell cycle progression, 
DNA rearrangement and repair, and adaptation 
to proapoptotic stimuli are hallmark features of 
developing thymocytes (  1  ). After successfully 
rearranging the TCR       subunit genes, double-
negative (DN) thymocytes undergo a wave of 
proliferation driven by ligand-independent ac-
tivation signals originating from the preTCR at 
the DN3 stage of development. Such signals in-
volve the down-regulation of p53-dependent 
cell cycle arrest and apoptotic programs as part of 
the       selection process (  2, 3  ). At a later stage of 
development, double-positive (DP) thymocytes 
no longer proliferate, but are instead exposed 
to a proapoptotic environment that is at least 
partially dependent on circulating steroid hor-
mones, as well as on other factors inducing ox-
idative stress (  4  ). These factors promote massive 
apoptosis of DP thymocytes (  “  death by neglect  ”  ) 
through p53-dependent and -independent mech-
anisms, which can be rescued by TCR-driven 
signals, to allow positive selection and further 
thymocyte maturation (  5  ). Thus, coordination 
of DNA rearrangement and repair with prolif-
erative and survival signals appears to be critical 
for thymocyte progression through various de-
velopmental stages. The mechanisms underlying 
this fi  nely regulated process are incompletely un-
derstood, as are the relative roles played by major 
pathways controlling survival. As progression 
from the DN to the DP stage is a swift process 
being completed in     24 h (  6  ), all of these steps 
have to rely on an extremely rapid course of 
action, possibly involving posttranscriptional, as 
well as posttranslational, control mechanisms. 
  The COP9 signalosome (CSN) is an evolu-
tionarily conserved, ubiquitously expressed (  7  ) 
multimolecular complex controlling the function 
of cullin-based ubiquitin ligase complexes (  8, 9  ). 
CSN5/JAB1 is the only subunit of the com-
plex endowed with catalytic activity (  10  ), and it 
was shown by both our group (  11  ) and another 
CORRESPONDENCE  
 Ruggero  Pardi: 
 pardi.ruggero@hsr.it
  Abbreviations used: ClC, 
cleaved eff  ector caspase; CSN, 
COP9 signalosome; DN, 
double-negative; DP, double-
positive; HRP, horseradish 
peroxidase; ISP, intermediate 
single-positive; PI, propidium 
iodide; SP, single-positive; UPS, 
ubiquitin-proteasome system. 
      The online version of this article contains supplemental material.   
  Targeted inactivation of the COP9 
signalosome impairs multiple stages
of T cell development 
    Martina     Panattoni  ,    1,2       Francesca     Sanvito  ,    2      Veronica     Basso  ,    2   
  Claudio     Doglioni  ,    1,2       Giulia     Casorati  ,    2       Eugenio     Montini  ,    3   
  Jeff  rey R.     Bender  ,    4       Anna     Mondino  ,    2     and   Ruggero     Pardi      1,2     
  1  Vita-Salute San Raffaele University School of Medicine, 20132 Milano, Italy 
  2  Department of Biological and Technological Research, Scientifi  c Institute San Raffaele, 20132 Milano, Italy 
  3  San Raffaele-Telethon Institute for Gene Therapy, 20132 Milano, Italy 
  4  Raymond and Beverly Sackler Foundation Cardiovascular Laboratory, Section of Cardiovascular Medicine, Yale University 
School of Medicine, New Haven, CT 06520   
  Genetic programs promoting cell cycle progression, DNA repair, and survival are coordi-
nately induced in developing T cells and require rapid turnover of effector molecules. As the 
COP9 signalosome (CSN) has been placed at the crossroads of these programs in lower 
organisms, we addressed its role by conditionally deleting   CSN5/JAB1  , its catalytic subunit, 
in developing thymocytes.   CSN5/JAB1  del/del     thymocytes show defective S phase progression 
and massive apoptosis at the double-negative (DN) 4  –  double-positive (DP) transition stage, 
which is paralleled by altered turnover of selected CSN-controlled substrates, including 
p53, I    B-    , and     -catenin. Combined dysregulation of the p53 and NF-    B pathways 
affects thymocyte survival by altering the mRNA and protein levels of selected Bcl-2 family 
members. Genetic complementation analysis performed on p53      /     , Bcl-xL/Bcl-2A1, or 
T cell receptor transgenic backgrounds indicates that CSN5/JAB1 acts at distinct develop-
mental stages to coordinate proliferation, survival, and positive selection of thymocytes by 
controlling the induction of defi  ned genetic programs acting downstream of CSN-regulated 
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CSN5/JAB1-defi  cient mice (  CSN5/JAB1  del/del    ). The lack of 
CSN5/JAB1 mRNA and protein in DN and DP thymocytes 
was demonstrated by semiquantitative RT-PCR and Western 
blot analysis (Fig. S1 B). In addition, genomic DNA prepared 
from sorted DN and DP/single-positive (SP) cells was analyzed 
by PCR using primers detecting WT, fl  oxed, or deleted alleles 
(Fig. S1 C). Most T cells in   CSN5/JAB1  del/del     mice showed a 
complete   CSN5/JAB1   deletion, as indicated by the presence 
of the deleted allele in thymocytes and peripheral T cells. At 
the DN stage,   CSN5/JAB1  del/del     thymocytes yielded exclusively 
the PCR product corresponding to deleted allele. In peripheral 
T cells, however, we detected considerable levels of the  CSN5/
JAB1  fl o x     allele, suggesting that the residual mature T cells had 
escaped Cre-mediated deletion (Fig. S1 D). In support of this 
interpretation, peripheral T cells, although severely reduced in 
number, displayed a predominant memory-eff  ector phenotype 
(CD44  high  CD62L        ) in CSN5/JAB1-defi  cient animals, suggest-
ing homeostatic expansion of a small pool of phenotypically 
normal, mature T lymphocytes (Fig. S2). 
  Thymic morphology, thymocyte counts, and subset 
distribution were comparatively assessed 5  –  6 wk after birth 
in   CSN5/JAB1  fl  ox/fl  ox     mice expressing the   LckCre   transgene 
(herein defi   ned as   CSN5/JAB1  del/del    ) and in littermates 
lacking   LckCre  . Thymi from   CSN5/JAB1  del/del     animals 
showed a severely hypoplastic medulla (  Fig. 1 A  ), a marked 
decrease in the proportion of DP and SP thymocytes 
(  Fig. 1 B  ), and an 80  –  90% reduction in thymocyte num-
ber (  Fig. 1 C  ), whereas the various subsets of DN thymo-
cytes, as determined by the expression of the CD44 and 
CD25 stage-specifi  c markers, were not signifi  cantly altered 
compared with the   CSN5/JAB1  fl  ox/fl  ox     littermate controls, 
both percentage-wise (  Fig. 1 B  ) and in absolute numbers 
(  Fig. 1 D  ).   These fi  ndings suggest that without a functional 
CSN, thymic development is blocked at a transition stage 
between DN4 and DP thymocytes or that emerging DP 
thymocytes are selectively lost as a consequence of   CSN5/
JAB1   deletion. 
  Defective cell cycle progression in CSN5/JAB1-defi  cient 
thymocyte subsets 
  The aforementioned defects in thymocyte maturation, as 
well as the reduced thymic cellularity in   CSN5/JAB1  del/del     
animals, could be explained by a decreased proliferative rate 
and/or by an increased apoptotic death. To discriminate be-
tween these possibilities, we assessed thymocytes  ’   competence 
to progress in the cell cycle by giving a short pulse (40 min) 
of BrdU in vivo, followed by simultaneous fl  ow cytometric 
analysis of BrdU incorporation and DNA content with 7-amino-
actinomycin staining, to quantitatively assess the various stages 
of the cell cycle. Overall,   CSN5/JAB1  del/del     thymocytes did 
not show quantitative defects in BrdU incorporation (  Fig. 2 A  ), 
suggesting that G1-to-S progression is not altered in the 
absence of CSN5/JAB1. However, a variable fraction of DN 
thymocytes, ranging from 12 to 28% in several indepen  -
dent experiments, appeared to be arrested in the S/G  2  /M 
phase in   CSN5/JAB1  del/del     mice and failed to incorporate BrdU. 
group (  12  ) to be an adhesion-regulated molecule required for 
adhesion- and TCR-dependent gene expression in T lympho-
cytes. Constitutive knockouts of various subunits of the CSN 
(  13, 14  ), including CSN5/JAB1 (  15  ), lead to an early embry-
onic phenotype featuring accumulation of potential substrates 
of CSN-regulated E3 ligases, such as p27  kip1  , cyclin E, and 
p53, suggesting that in vivo the CSN is a positive regulator of 
such ubiquitin ligase complexes. Several studies have impli-
cated the CSN in the regulation of proteins critical for the 
control of cellular proliferation. Among the E3 ligase sub-
strates that could become altered via altered CSN function 
are the cyclin-dependent kinase inhibitors p27   kip1   (  16, 17  ), 
p57, p21  cip1   (  18  ), and their transcriptional regulators (i.e., 
SMAD4 and SMAD7) (  19, 20  ), as well as several cyclins (cyclin 
D1, E, and B1) (  21  ). Multiple subunits in the CSN have also 
been implicated in DNA damage sensitivity and repair (  22  ). 
A factor potentially aff  ected by CSN misregulation is Cdt1 
(  23, 24  ), which is a replication initiator protein that is regu-
lated by the CSN after irradiation damage. Interestingly, CSN 
interaction with p53 has been shown to target this tumor 
suppressor for degradation, greatly aff  ecting the ability of the 
cells to respond to DNA damage and proceed through the cell 
cycle or signal for apoptosis (  25, 26  ). 
  We hypothesize that the CSN could play a central role 
in the coordinate regulation of cell proliferation, DNA re-
pair, and apoptosis in developing thymocytes. To test this 
hypothesis, as well as to gain insight into the function of 
the CSN in vivo, we conditionally deleted CSN5/JAB1, 
which is the CSN  ’  s catalytic subunit, in developing thymo-
cytes, based on prior evidence (  8  ) showing that ablation of 
CSN5/JAB1 would lead to functional inactivation of the 
entire CSN. 
    RESULTS   
  CSN5/JAB1 is essential for T cell lineage development 
  To address the function of CSN5/JAB1 in thymic develop-
ment, we generated mice targeted with   loxP   sites at the   CSN5/
JAB1   locus for conditional deletion by Cre recombinase (Fig. 
S1 A, available at http://www.jem.org/cgi/content/full/
jem.20070725/DC1). We used a strategy based on both Cre- 
and Flp-mediated recombination to generate a selection marker –
  free locus fl  anked by recombinase-specifi  c sites. Cre-mediated 
removal of exon 2 resulted in an early frameshift and translation 
termination. Heterozygous   CSN5/JAB1  +/Neofl  ox     mice were vi-
able and fertile. In vivo Flp-mediated excision of the PGK-
Neo cassette was obtained by mating the   CSN5/JAB1  +/Neofl  ox     
mice to the FLPe deleter strain. After germ line transmission of 
the   CSN5/JAB1  fl o x     allele to the progeny, correct excision of 
the selection marker cassette was confi   rmed by PCR and 
Southern blot analysis. Mice homozygous for the fl  oxed 
  CSN5/JAB1   allele (  CSN5/JAB1  fl  ox/fl  ox     mice), which were de-
veloped normally with unperturbed CSN5/JAB1 expression 
(unpublished data), were generated at the expected Men-
delian ratio and appeared phenotypically indistinguishable from 
their age-matched WT. We crossed   CSN5/JAB1  fl  ox/fl  ox     mice 
with the   LckCre   deleter strain to generate thymocyte-specifi  c JEM VOL. 205, February 18, 2008 
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the severe reduction in DP thymocyte numbers observed in 
  CSN5/JAB1  del/del     mice. Therefore, we comparatively assessed 
the rate of apoptotic death in developing   CSN5/JAB1  del/del   
  versus WT thymocytes. Immunohistochemical detection of 
apoptotic cells by cleaved eff  ector caspase 3 (ClC3) staining 
revealed that the apoptotic rate was increased by more than 
threefold in   CSN5/JAB1  del/del     thymi (  Fig. 3 A  ). ClC3  +   cells 
ranged from 1.5  ±   0.4% in WT to 5.6  ±   0.7% in  CSN5/JAB1  del/del     
thymi in three separate experiments. Increased propensity to 
undergo apoptosis by   CSN5/JAB1  del/del     thymocytes was con-
fi  rmed by assessing apoptotic death in cells cultured ex vivo 
for various time points ( Fig. 3 B ). As previously reported, nor-
mal thymocytes undergo spontaneous apoptosis after 24 h 
in culture, with 38   ±   12% apoptotic cells at the end of the 
culture period, particularly aff  ecting the DP subset. Thymo-
cytes from   CSN5/JAB1  del/del     mice were more prone to un-
dergo spontaneous apoptosis than  CSN5/JAB1  fl  ox/fl  ox     littermates 
in both DN and DP subsets, with values being already higher 
at time 0 after isolation and approaching 100% after 24 h in 
culture (  Fig. 3 B  ). Thus, the greatly reduced thymic cellularity 
By electronically gating onto the DN versus DP subsets, we 
found that S/G  2  /M phase  –  arrested thymocytes were also pre-
sent in the DP fraction (  Fig. 2 A  ).   To follow developmental 
progression of actively proliferating cells, we chased BrdU  +   
thymocytes at various time points after the initial pulse label in 
separate groups of mice. As shown in   Fig. 3 B  , BrdU  +   DN 
thymocytes accumulate throughout the chase period in 
  CSN5/JAB1  del/del     mice, with minimal progression toward the 
DP stage.   In contrast, DN thymocytes appear to rapidly 
progress into DP subsets in WT littermates (  Fig. 2 B  ), with a 
fraction of them turning into SP cells that migrate to the pe-
riphery at later time points (not depicted). This, again, sug-
gests that DN thymocytes show delayed/arrested S phase 
progression in CSN5/JAB1-defi  cient animals. 
  Increased apoptosis in DN and DP thymocytes 
in   CSN5/JAB1  del/del     mice 
  The aforementioned fi  ndings suggest that defective cell cycle 
progression by DN thymocytes, although clearly detectable 
in a fraction of proliferating cells, is unlikely to account for 
    Figure 1.         Impaired thymocyte development in CSN5/JAB1    del/del     mice.   (A) Low magnifi  cation, hematoxylin and eosin  –  stained sections of thymi from 
WT (top) or CSN5/JAB1    del/del    (bottom) 5-wk-old mice show a greatly reduced medullary area, which is indicative of defective maturation of thymocytes in 
the absence of a functional CSN. Bar, 100   μ  m. M, medulla; C, cortex. (B) Thymocyte suspensions were stained with anti-CD4 plus anti-CD8 antibody to 
identify the major thymocyte subsets, and with anti-CD44 plus anti-CD25 antibody to detect the various subsets of DN thymocytes in WT (left) versus 
CSN5/JAB1    del/del    (right) mice. Percentage values for the various subsets are shown in the respective quadrants. (C) Thymic cellularity, as estimated by 
  calculation of the number of thymocytes from individual thymi after electronic gating of the various subsets. Numbers are the mean   ±   the SD of values 
obtained from 25 mice per genotype at 5  –  6 wk of age. *, P   <   0.001 (Student  ’  s two-tailed   t   test with equal variance). (D) DN subset distribution, calculated 
as in C, but after assessing the various DN subsets with anti-CD44 and -CD25 antibodies to identify DN1 (CD44  + ;  CD25       ), DN2 (CD44  + ;  CD25 + ),  DN3 
(CD44    ;  CD25 +  ), and DN4 (CD44    ;  CD25       ) subsets.  468 CSN DEFICIENCY IMPAIRS T CELL DEVELOPMENT | Panattoni et al.
we extracted total RNA from isolated DP/SP populations 
and amplifi  ed the cDNA by PCR using a panel of V      oligos 
in combination with a C     -specifi  c primer, followed by 
hybridization of V     -C      PCR products with a panel of J      
oligoprobes selected from the 5     -most to the 3     -most J      seg-
ments. Results showed no skewing in J      segment usage in 
  CSN5/JAB1  del/del     thymocytes (Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20070725/DC1). Fur-
thermore, we performed heteroduplex analysis to evaluate 
the heterogeneity of the V      and V      repertoire on three rep-
resentative V      segments, and within each V      family. We ob-
served that both TCR       and       subunit rearrangement is 
qualitatively not aff  ected in   CSN5/JAB1  del/del     mice (unpub-
lished data). Collectively, these fi  ndings indicate that rear-
rangement of the TCR is qualitatively not aff  ected by the 
lack of a functional CSN in developing thymocytes. How-
ever, we found that a measurable fraction of   CSN5/JAB1  del/del     
and the developmental block in   CSN5/JAB1  del/del     mice are 
compatible with a combined defect in cell cycle progression and 
survival of developing thymocytes at the DN  –  DP transition. 
  TCR gene rearrangement proceeds normally in CSN5/JAB1-
defi  cient thymocytes 
  Although   CSN5/JAB1  del/del     thymocytes had no apparent de-
fects in DN3 –  DN4 stage progression, suggesting that a preTCR 
was correctly formed and was competent to transduce prolif-
erative signals inherent to the       selection process, we assessed 
the expression and rearrangement of TCR       subunits in 
  CSN5/JAB1  del/del     versus WT littermates. Expression of a pro-
ductively rearranged TCR       subunit was detected intracellu-
larly in DN and DP thymocytes. To characterize the effi   ciency 
of the       selection process and the subsequent steps in TCR 
rearrangement at the DP stage, we assessed the extent of 
V(D)J recombination at the   TCR       and          loci. To this aim, 
    Figure 2.         Altered cell cycle progression in developing CSN5/JAB1    del/del     thymocytes.   (A) Cell cycle progression was assessed by a short (40-min) 
pulse of i.p. injected BrdU, followed by total thymocyte isolation and staining with FITC-conjugated anti-BrdU antibody, to detect DNA-replicating cells, 
combined with 7-amino-actinomycin staining as a measure of DNA content. Flow cytometry was performed on electronically gated DN (top) or DP (bottom) 
thymocytes from WT (left) or CSN5/JAB1    del/del    thymocytes. Percentage values for G0/G1 (2N DNA content), S (intermediate DNA content), and G2/M 
(4N DNA content) cells are shown in the respective regions. Shown is a representative experiment out of eight independent ones performed. (B) BrdU 
pulse-chase analysis. 4 mice per time point for each genotype (WT, fi  lled squares; CSN5/JAB1    del/del   , empty squares) were given a 40-min pulse with i.p. 
injected BrdU, after which one group of mice per genotype was killed immediately (time 0) or at the indicated time points. Thymocytes were isolated, 
counted, and stained with FITC-conjugated anti-BrdU combined with surface staining with anti-CD4 and -CD8 antibodies to electronically gate DN and 
DP cells by fl  ow cytometry. Shown is the number of BrdU  +   thymocytes (mean   ±   the SD for each group of animals) gated as DN or DP by fl  ow cytometry. 
*, P   <   0.005; **, P   <   0.001 (Student  ’  s two-tailed   t   test with equal variance).     JEM VOL. 205, February 18, 2008 
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transgenic TCR, as detected by antibodies to V     2/V     5. 
In contrast, thymi from   CSN5/JAB1  del/del     OT-II mice had 
only 2  –  8% the number of CD4  +   SP cells found in control 
animals (Table S1), and such impairment in transgenic TCR 
diff  erentiation and survival was even more evident in pe-
ripheral blood (Table S1). Thus, providing a productively re-
arranged TCR that is positively selected on a MHC class II 
molecule is not suffi   cient to rescue survival and/or diff  erentia-
tion of CD4  +   SP thymocytes in the absence of a functional 
  CSN5/JAB1   locus. 
  Selected E3 ligase substrates accumulate
in   CSN5/JAB1  del/del     thymocytes 
  Previous studies have shown that inactivation of the CSN 
in vivo impairs the function of cullin-based ubiquitin ligase 
complexes, resulting in the accumulation of substrates that 
largely account for the observed phenotypes (  9  ). Given the 
large number of substrates that are potentially controlled by 
the CSN, we sought to establish a correlation between the 
intracellular levels of such substrates and the phenotypes ob-
served in   CSN5/JAB1  del/del     mice. To this aim, purifi  ed DN 
and DP thymocytes from multiple animals were pooled (4  –  5 
animals/pool on average) based on the severity of the thymic 
phenotype, as determined by assessing the ratio between DN 
and DP thymocyte subpopulations. Such ratio ranges from 
  <  0.05 in WT mice, to   >  4 in   CSN5/JAB1  del/del     animals dis-
playing a severe phenotype. Intermediate phenotypes may be 
explained by the incomplete penetrance of the Lck pro-
moter-driven expression of Cre recombinase, resulting in in-
effi   cient deletion of the   CSN5/JAB1   locus in a variable fraction 
of developing T cells (Fig. S5, available at http://www.jem
.org/cgi/content/full/jem.20070725/DC1) (  28  ). We assessed 
candidate substrates of CSN-controlled ubiquitin ligases whose 
dysregulated steady-state levels, which were caused by defec-
tive ubiquitin-proteasome system (UPS)  –  dependent degra-
dation, might account for the observed cell cycle and survival 
defects in   CSN5/JAB1  del/del     thymocytes. Within the former 
category, we included the cyclin-dependent kinase inhibitors 
p27  kip1   and p21  cip1  , cyclin D3, cyclin E, and the DNA repli-
cation licensing factor Cdt1, whereas c-Myc, p53,      -catenin, 
the glucocorticoid receptor, and I     B-      were investigated as 
UPS-controlled proteins involved in the regulation of sur-
vival/apoptotic programs. Finally, to assess the effi   ciency of 
  CSN5/JAB1  del/del     locus deletion in the pooled DN and DP/SP 
populations and to gain insight into the reduced function of 
the CSN, we biochemically analyzed the steady-state levels 
of CSN5/JAB1, cullin1, and the Cre recombinase (  Fig. 4 A  ).   
Some substrates were poorly detectable in purifi  ed thymo-
cytes (e.g., c-Myc and p21  cip1  ; not depicted). Conversely, as 
shown in   Fig. 4 B  ,      -catenin and p53 were the only sub-
strates whose steady-state levels paralleled the severity of the 
thymic phenotype in   CSN5/JAB1  del/del     mice.      -catenin, in 
particular, showed a mean 20-fold accumulation in DP thymo-
cytes from the most severely aff  ected animals, whereas p53, 
which is barely detectable in WT thymocytes, accumulated 
to clearly detectable levels in   CSN5/JAB1  del/del     developing 
thymocytes underwent progression from DN to DP/SP stages 
(the latter is more evident in SP CD8  +   cells) without express-
ing a productively rearranged, intracellular TCR       subunit, 
suggesting a partial impairment of the       selection process 
(Fig. S4). 
  CSN5/JAB1 is required for TCR-driven signals involved
in positive selection 
  The greatly enhanced apoptotic rate of   CSN5/JAB1  del/del     
DP cells suggested that most developing thymocytes in 
  CSN5/JAB1  del/del     animals die   “  by neglect  ”   before undergo-
ing positive selection, as this process is believed to rescue 
just a small fraction of DP cells from apoptotic death (  1  ). 
To further address this issue, we crossed the OT-II transgenic 
TCRs, which are restricted by MHC class II molecules and 
undergo positive selection in C57BL6 mice not expressing 
the antigenic peptide (  27  ), onto the   CSN5/JAB1  del/del     back-
ground. As in   CSN5/JAB1  del/del     mice, thymic cellularity 
was reduced     90% in compound   CSN5/JAB1  del/del     OT-II 
mice compared with the   CSN5/JAB1  fl  ox/fl  ox     OT-II controls 
(Table S1, available at http://www.jem.org/cgi/content/full/
jem.20070725/DC1). As expected, thymi from 5  –  6-wk-old 
OT-II mice contained mainly CD4  +   SP cells expressing the 
    Figure 3.         Increased apoptosis in developing CSN5/JAB1    del/del     thy-
mocytes.   (A) Immunohistochemical sections of 5-wk-old thymi from WT 
(left) or CSN5/JAB1    del/del    (right) mice stained with anti-cleaved caspase 3 
antibody to detect apoptotic cells (as revealed by HRP immunoenzymatic 
reaction). Bar, 50      m. (B) Isolated thymocytes from WT (fi  lled squares) or 
CSN5/JAB1    del/del    (empty squares) mice were cultured in complete tissue 
culture medium for the indicated time points, after which the rate of 
apoptosis was assessed by fl  ow cytometry as indicated in the Materials 
and methods section. Electronic gating was performed to quantify apop-
tosis in DN and DP thymocyte subsets. Data are the mean   ±   the SD 
of values obtained from eight independent experiments. *, P   <   0.05; 
**, P   <   0.001 (Student  ’  s two-tailed   t   test with equal variance).     470 CSN DEFICIENCY IMPAIRS T CELL DEVELOPMENT | Panattoni et al.
  Altered levels of Bcl-2 family proteins and defective
NF-    B activation in developing thymocytes
of   CSN5/JAB1  del/del     mice 
  We were intrigued by the fi  nding that the levels of      -catenin 
and I     B-     , both of which are known substrates of the CSN-
controlled SCF       TrcP1   E3 ligase, showed opposite variations in 
  CSN5/JAB1  del/del     DP thymocytes when compared with WT 
littermates. We reasoned that because I     B-      is a direct tran-
scriptional target of NF-     B as part of a well-characterized 
regulatory feedback loop (  29  ), its reduced levels could be ex-
plained by defective induction of NF-     B, possibly caused by 
delayed or ineffi   cient degradation of its cytoplasmic inhibitor. 
To test this possibility, we used several approaches. First, we 
quantitatively assessed the steady-state levels of the I     B-      
mRNA, which showed a marked reduction in both   CSN5/
JAB1  del/del     DN and DP cells compared with WT controls and 
paralleled the severity of the phenotype (Table S2). Second, 
we performed short-term activation assays in freshly purifi  ed 
DN4 thymocytes by exposing them in vitro to combined 
stimulation via PMA plus ionomycin (P + I), which is a known 
NF-     B  –  activating condition that promotes rapid phosphory-
lation, polyubiquitination, and UPS-dependent degradation 
of I     B-     , followed by nuclear translocation of transcription-
competent NF-     B dimers. As shown in   Fig. 5  , steady levels 
of I     B-      decreased rapidly in WT thymocytes upon P + I 
treatment.   Nuclear levels of p65  RelA   were clearly detectable 
in unstimulated cells, which is consistent with a constitutive 
induction of NF-     B in DN4 cells (  30  ), and accumulated fur-
ther upon P + I stimulation. In contrast, both steady-state I     B-      
and nuclear p65 levels were greatly reduced in   CSN5/JAB1  del/del    , 
unstimulated DN4 thymocytes. However, a sizeable fraction 
of p65  RelA   did accumulate in the nucleus of P + I  –  stimulated 
  CSN5/JAB1  del/del     cells. 
  The apparent dysregulation of NF-     B observed in 
  CSN5/JAB1  del/del     thymocytes prompted us to assess the levels 
DP cells. Likewise, cyclin D3 and Cdt1 levels were moder-
ately increased in DN thymocytes from   CSN5/JAB1  del/del     
mice, whereas in DP thymocytes the levels of Cdt1 were 
directly proportional to the severity of the phenotype (  Fig. 4 B  ). 
At variance with the aforementioned fi  ndings, the levels of 
I     B-      showed an inverse correlation with the severity of the 
phenotype in both DN and DP cells from   CSN5/JAB1  del/del     
mice (  Fig. 4 B  ). Unexpectedly, the levels of p27  kip1   were also 
consistently reduced in   CSN5/JAB1  del/del     DN cells, whereas 
they did not diff  er from controls in DP thymocytes (  Fig. 4 B  ). 
Finally, cyclin E (unpublished data), did not show signifi  cant 
variations in developing thymocytes from   CSN5/JAB1  del/del     
animals when compared with WT littermates. Quantitative 
PCR analysis for      -catenin and p53 expression confirmed 
that the observed increase in their protein levels could not be 
accounted for by an increase in steady-state transcript levels 
(Table S2). 
    Figure 4.         Substrates of CSN-regulated E3 ligases are dysregulated 
CSN5/JAB1    del/del     thymocytes.   Purifi  ed DN and DP/SP thymocytes from 
pools of 4 to 5 animals belonging to either WT or to each of the indicated 
CSN5/JAB1 knockout phenotypes (S, severe; Mo, moderate; Mi, mild; 
Fig. S5 shows phenotypic clustering of CSN5/JAB1    del/del    thymocytes  based 
on the DN:DP/SP ratio), likely resulting from incomplete penetrance of 
  Lck-Cre  -mediated recombination, were lysed and subjected to SDS-PAGE 
followed by immunoblotting with the indicated antibodies. (A) Immunoblot 
analysis for CSN5/JAB1, Cre, and Cul1 in purifi  ed DP/SP thymocytes. Cul1 
is visualized as a doublet with the upper band representing the hyper-
neddylated isoform. (B) Immunoblot analysis for candidate substrates 
of CSN-regulated E3 ligases. Films were processed by densitometric 
scanning and normalized to values for      -actin for each lane to assess 
the relative values in each lane. Fig. S5 is available at http://www.jem
.org/cgi/content/full/jem.20070725/DC1.   
    Figure 5.         Deregulated NF-    B activation in developing thymocytes 
from CSN5/JAB1    del/del     mice.   Purifi  ed DN4 thymocytes were pooled from 
4  –  5 WT or CSN5/JAB1    del/del    mice and either left untreated or stimulated 
with a combination of 50 nM PMA plus 250      M ionomycin for 45 min, 
after which cells were lysed and cytosolic and nuclear extracts were pre-
pared as described in the Materials and methods and run on a SDS-PAGE. 
Immunoblots were performed with the indicated antibodies.     JEM VOL. 205, February 18, 2008 
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hematopoietic progenitor cells (  Fig. 8 A   and not depicted).   
The ability of Bcl-xL to rescue survival of   CSN5/JAB1  del/del     
thymocytes was confi  rmed by assessing the apoptotic rate of 
ex vivo  –  cultured, purifi  ed thymocytes (  Fig. 8 B  ). The appar-
ent inability of Bcl-2A1 to aff  ect survival of   CSN5/JAB1  del/del     
thymocytes was not caused by ineffi   cient integration of the 
lentiviral vector carrying the Bcl-2A1 transgene (not de-
picted) or to reduced expression of the Bcl-2A1 protein, as 
shown by the increase in protein levels (three- to fi  vefold 
over the endogenous proteins for both Bcl-2A1 and Bcl-xL) 
in long-term cultures of virally transduced bone marrow pre-
cursors (  Fig. 8 C  ). 
of selected members of the Bcl-2 protein family, some of 
which are known direct NF-     B targets and are prominent 
eff  ectors of the survival programs controlled by this tran-
scription factor in developing thymocytes (  31, 32  ). To this 
aim, we used a combination of biochemical, immunohisto-
chemical, and genetic approaches. Although Bcl-2 levels, 
which are up-regulated in DP thymocytes, did not appear to 
be aff  ected in   CSN5/JAB1  del/del     animals (not depicted), the 
levels of Bcl-xL were markedly down-regulated in both DN 
and DP cells from knockout animals. Such down-regulation 
was evident both at the mRNA and at the protein level 
(  Fig. 6, A and B  ).   Likewise, the antiapoptotic Bcl-2A1 pro-
tein, which is also a target of NF-     B, was down-regulated 
in   CSN5/JAB1  del/del     thymocytes (  Fig. 6 A  ). Conversely, the 
proapoptotic protein Bax, which is a target of p53, was up-
regulated in   CSN5/JAB1  del/del     DN and DP cells (  Fig. 6 A  ), 
which is consistent with the increased levels of p53 in these 
cells. As a result, the ratio between Bax and Bcl-xL or Bax 
and Bcl-2A1 was completely subverted in both DN and DP 
cells from   CSN5/JAB1  del/del     animals compared with WT lit-
termates (  Fig. 6 A  ), thus potentially accounting for the increased 
apoptotic rate observed in developing thymocytes from the 
knockout mice. 
  Impaired survival in CSN5/JAB1-defi  cient thymocytes
is independent of p53, but can be rescued by transgenic 
Bcl-xL expression 
  To genetically assess the pathways involved in   CSN5/JAB1  del/del    -
defective T cell development and enhanced apoptosis, and 
to gain insight into the role of the CSN in p53 functional 
regulation, the   CSN5/JAB1  del/del     mutation was introduced 
into the p53       /    background. Phenotypic characterization of 
developing thymocytes in   CSN5/JAB1  del/del     p53       /       animals 
showed that lack of p53 does not rescue the reduced thymic 
cellularity resulting from CSN5/JAB1 defi  ciency. However, 
a defi  ned subset of thymocytes (intermediate SP [ISP]) re-
fl  ecting a transitional state between DN and DP cells, was 
greatly increased in the compound   CSN5/JAB1  del/del     p53       /       
knockout mice compared with the individual knockouts 
(  Fig. 7, A and B  ).   Thus, inactivation of CSN5/JAB1 unveils 
a critical role of p53-dependent apoptosis in this particular 
stage of thymocyte development. 
  To directly assess if reduced expression of selected Bcl-2 
family members was responsible for the increased apoptotic 
rate of   CSN5/JAB1  del/del     thymocytes, we transduced   CSN5/
JAB1  del/del     hematopoietic progenitor cells with self-inactivating 
lentiviral vectors expressing Bcl-xL, Bcl-2A1, or GFP (as 
a control) and transplanted transduced cells into sublethally 
irradiated RAG1       /       recipients. At 6 wk after transplant, we 
monitored the phenotypes and absolute counts of developing 
thymocytes and performed ex vivo cultures to assess the sur-
vival ability of transduced cells. As shown in   Fig. 8 A  , forced 
expression of Bcl-xL, but not Bcl-2A1, favored the accumu-
lation of both DN4 and SP CSN5/JAB KO thymocytes to 
levels comparable to those found in fl  oxed, Cre        -irradiated 
controls and RAG1       /       recipients reconstituted with WT 
    Figure 6.     Altered mRNA and protein levels of Bcl-2 family mem-
bers in CSN5/JAB1    del/del     thymocytes.   (A) Semiquantitative RT-PCR for 
the indicated Bcl-2 family members was performed on retrotranscribed 
total RNA extracted from purifi  ed DN and DP thymocytes obtained from 
pools of 4  –  5 animals, belonging to either WT or to each of the indicated 
CSN5/JAB1 knockout phenotypes (KO  m  , mild; KO  s  , severe; Fig. S5 shows 
phenotypic clustering of CSN5/JAB1  del/del   thymocytes based on the DN:
DP/SP ratio). Values were normalized on      -actin for each sample and 
expressed as fold induction over the expression levels detected in WT, DN 
thymocytes for each Bcl-2 family member. (right) The normalized densi-
tometric ratios of Bax:Bcl-xL and Bax:Bcl-2A1 values. Error bars indicate 
the mean   ±   the SD of three separate experiments. (B) Immunohisto-
chemical sections of 5-wk-old thymi from WT (left) or CSN5/JAB1    del/del   
(right) mice stained with anti-Bcl-xL antibody (as revealed by HRP 
immunoenzymatic reaction). M, medulla; C, cortex. Bcl-xL shows a typical 
dotted distribution in WT thymocytes, which is particularly evident in the 
thymic cortex. (right) Arrows indicate isolated, strongly positive thymic 
epithelial cells in CSN5/JAB1    del/del    thymi, which otherwise show barely 
detectable expression of Bcl-xL compared with WT controls (left). Fig. S5 
is available at http://www.jem.org/cgi/content/full/jem.20070725/DC1. 
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arrested S phase progression. This suggests that   CSN5/JAB1  -
defi  cient DN4 thymocytes fail to override a critical S phase 
checkpoint, resulting in cell cycle delay/arrest. We interpret 
the reduced steady-state levels of p27  kip1   observed in   CSN5/
JAB1  del/del     DN cells as a further indication that they are arrested 
in S phase, as Skp2-mediated degradation of p27  kip1   is maximal 
in cells undergoing DNA replication (  33  ). Altered cell cycle 
progression in   CSN5/JAB1  del/del     DN thymocytes does not ap-
pear to trigger a generalized apoptotic response, at least during 
the experimental time window (48 h) we examined. However, 
  CSN5/JAB1  del/del     DN4 thymocytes fail to accumulate, sug-
gesting that they do undergo apoptotic death (see the follow-
ing paragraphs in Discussion) and that a variable fraction of 
these cells does progress toward further stages of maturation. 
The fi  nding that forced expression of a rearranged transgenic 
TCR (OT-II) fails to rescue DP and SP development further 
supports the possibility that the TCR directly regulates the 
activity of the CSN while signaling selection/survival of 
DP thymocytes. 
  Among the candidate substrates we assessed as potentially 
accounting for the above cell cycle abnormalities in DN cells, we 
found no accumulation of p27  kip1   and cyclin E, which have been 
proposed to alter cell cycle progression in CSN-defi  cient, trans-
formed cell lines (  17, 21  ). Instead, we observed marked accumu-
lation of      -catenin and p53, which cannot be accounted for by 
their increased steady-state mRNA levels. Further, we observed 
a sizeable increase in the levels of the DNA replication initiation 
factor Cdt1, which paralleled the severity of the phenotype. 
    DISCUSSION   
  In this study, we addressed the function of the CSN in mam-
malian T cell development, as prior evidence in lower orga-
nisms suggested that it plays a pivotal role in the coordination 
of developmental programs entailing proliferation, diff  erenti-
ation, and survival in response to microenvironmental cues. 
The current model states that the hierarchical role of the CSN 
hinges on the functional regulation of cullin-based ubiquitin 
ligases, whose substrates are specifi  cally devoted to directing the 
onset and maintenance of the aforementioned developmental 
programs (  8, 9  ). Thus far, genetic evidence supporting this as-
sumption is lacking in mammals, as the constitutive deletion 
of various CSN subunits leads to early embryonic lethality. 
  In view of our fi  ndings, it appears that timely control of 
the half-life of protein substrates of a defi  ned subset of CSN-
regulated E3 ligases is essential for the rapid and coordinate 
progression of maturing T cells through the various check-
points imposed by TCR gene rearrangement, expression, and 
signaling. Overall, preTCR expression and proximal signaling 
appear to be preserved in CSN5/JAB1-defi  cient mice, as 
  CSN5/JAB1  del/del     DN3 thymocytes progress normally toward 
the DN4 stage and undergo qualitatively normal rearrange-
ments of TCR       and       subunit genes. In contrast, both DN4 
and DP developmental stages are substantially altered in 
  CSN5/JAB1  del/del     thymocytes.   CSN5/JAB1  del/del     DN4 cells do 
not show gross numerical abnormalities compared with WT 
littermates. However, a sizeable fraction of DN4 cells displays 
defective progression in the cell cycle, as indicated by a delayed/
    Figure 7.         Genetic complementation by a p53-defi  cient background only partially rescues thymic development in CSN5/JAB1    del/del     mice.  
(A) Thymocyte suspensions from the indicated genotypes were stained with anti-CD4 plus anti-CD8 antibody to identify the major thymocyte subsets. 
Dashed vertical lines were set to separate DN from ISP cells on the horizontal axis (showing CD8 expression levels). (B) Thymic cellularity of the indicated 
genotypes, as estimated by calculation of the number of thymocytes from individual thymi after electronic gating of the various subsets as shown in (A). 
Numbers are the mean   ±   the SD of values obtained from 3 mice per genotype at 5  –  6 wk of age.     JEM VOL. 205, February 18, 2008 
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mediated excision results in defective G1-to-S transition of 
DN4 cells and in moderately decreased thymocyte numbers 
(  35  ). Conversely, expression of a stabilized      -catenin mutant 
in developing thymocytes by in-frame deletion of a fl  oxed 
exon 3 yields a striking phenotype, featuring forced matura-
tion of DN cells into DP subsets before productive TCR 
gene rearrangement, as well as increased apoptosis of DP cells 
and reduced cellularity (  36  ). In apparent contrast, transgenic 
overexpression of stabilized      -catenin under a CD4 promoter 
results in increased DP cell survival, correlating with in-
creased steady-state levels of antiapoptotic Bcl-2 family mem-
bers (  37  ). In agreement with the study by Gounari et al. (  36  ), 
and with evidence obtained in SIP-1 (  38  ) and        TrCP1  -null 
cells (  34  ), we observed that in   CSN5/JAB1  del/del     thymocytes 
     -catenin accumulation correlates with defective cell cycle 
progression and a propensity to undergo apoptotic cell death. 
We also noticed that a measurable fraction of   CSN5/JAB1  del/del     
DP/SP cells fails to express a rearranged intracellular TCR 
compared with WT controls, which is compatible with an 
abnormal gain of function phenotype caused by dysregulated 
turnover of      -catenin (  36, 39  ). Notably, prior evidence sug-
gested that overexpression of      -catenin leads to enhanced 
stability of p53 in selected cell types (  40  ). However, notable 
phenotypic diff  erences exist between   CSN5/JAB1  del/del     mice 
and the      -catenin  –  overexpressing thymocytes reported by 
Gounari et al. (  36  ). This, along with the incomplete rescue of 
the   CSN5/JAB1  del/del     phenotype by the p53       /       background, 
suggests that elevation of p53 is not a direct a consequence of 
     -catenin accumulation in CSN5/JAB1  del/del   T cells and is un-
likely to account for the observed phenotype. Rather, direct 
control of p53 protein stability by CSN-regulated E3 ligase 
complexes, such as Mdm2 itself or COP1 (  26  ), might be im-
paired in the absence of a functional CSN. Notably, breeding 
the CSN5/JAB1 defi  ciency onto a constitutive p53  null   back-
ground does promote a relevant shift in thymocyte diff  erenti-
ation toward an ISP phenotype. This indicates that a critical 
p53-dependent checkpoint lies between DN4 cells and the 
immediate next step in thymocyte maturation, which involves 
exit from the cell cycle. A similar role for p53 has been sug-
gested by a prior study investigating the role of the transcrip-
tional regulator Bcl11b in thymic development (  41  ). Further 
dissection of the aforementioned processes awaits the com-
prehensive identifi  cation of cell cycle checkpoint regulators 
that are under direct control by the CSN. 
  Increased propensity to undergo apoptotic death is a 
prominent feature of   CSN5/JAB1  del/del     thymocytes at multi-
ple developmental stages, and it is likely to account for the 
marked decrease in thymic cellularity observed in these mice. 
CSN5/JAB1  del/del   DN and DP cells display increased apopto-
sis both in vivo and after in vitro culture, suggesting an im-
balance in critical eff  ectors of death and survival programs. 
We uncovered a major decrease of both Bcl-xL and Bcl-2A1 
transcript and protein levels in   CSN5/JAB1  del/del     DN, as well 
as in DP cells, whereas the relative levels of Bcl-2 seemed 
unchanged compared with WT littermates. Coupled to the 
increased levels of the p53 transcriptional target Bax, which 
  As a key eff  ector of the Wnt signaling pathway,      -catenin 
is polyubiquitinated and routed to proteasomal degradation 
by the SCF       TrCP1   ubiquitin ligase complex, whose function is 
under direct positive regulation by the CSN (  34  ). Thus, it is 
possible that a dysregulated turnover of      -catenin underlies 
selected phenotypic traits in CSN5/JAB1  del/del   T cells. The 
existing literature concerning the role of      -catenin through-
out thymocyte development is somewhat controversial. 
Conditional deletion of a fl  oxed      -catenin locus by   LckCre  -
    Figure 8.     Transgenic expression of Bcl-xL rescues the number and 
late developmental stages of   CSN5/JAB1  del/del     thymocytes.   (A) DN, DP, 
and SP thymocyte counts from individual Rag1      /      animals 6 wk after 
reconstitution with bone marrow progenitors transduced with the indi-
cated transgenes (  CSN5/JAB1  flox/flox    animals were used as controls). 
(B) Viability of DN and DP thymocytes from chimeric animals as described 
above, after ex vivo culture for the indicated time points and fl  ow cyto-
metric analysis with FITC-Annexin V staining and electronic gating on the 
indicated subsets; (C) Immunoblot analysis for Bcl-2A1 and Bcl-xL expres-
sion in bone marrow precursors 2 wk after transduction with lentiviral 
vectors carrying the indicated transgenes.      -actin was used for normal-
ization. *, P   <   0.05; **, P   <   0.005; ***, P   <   0.001 (Student  ’  s two-tailed   t   test 
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also provide an indication that the CSN is required to allow 
survival of positively selected DP thymocytes, as shown by 
the failure of the OT-II transgenic TCR to rescue survival 
and maturation of DP cells in a CSN5/JAB1-defi  cient gene-
tic background. 
  Proliferation and survival of developing thymocytes de-
pend on appropriate signals delivered by the preTCR, the 
successful completion of a poorly defi  ned process of DNA 
recombination and repair, and the appropriate coordination 
of processes aff  ecting progression through and exit from the 
cell cycle. All of the aforementioned processes occur ex-
tremely rapidly, as the transition between DN4 and DP stages 
takes on average   <  24 h to be completed (  6  ). Collectively, our 
fi  ndings suggest that the CSN exerts a general coordinating 
role on key signaling pathways in thymic development by 
controlling rapid posttranslational turnover of critical sub-
strates. Although the CSN may extend its role throughout 
thymic development, the transition stage between actively 
proliferating DN4 cells and emerging DP thymocytes, which 
must survive a hostile microenvironment while editing a func-
tional TCR, seem most critically dependent on a functional 
CSN. By conditionally deleting   CSN5/JAB1   in other cell 
types, it will be important to address whether such a role of 
the CSN is context-dependent or can be extended to other 
developmental processes entailing a fi  ne balance between pro-
liferation and survival. 
    MATERIALS AND METHODS   
  Generation of mice carrying fl  oxed   CSN5/JAB1   alleles and   Lck-Cre   
transgenes.     A targeting vector was constructed by subcloning the desired re-
gion of a BAC clone containing the entire   CSN5/JAB1   genomic sequence 
into the pFlrt-Neo vector. The targeting construct includes a neomycin resis-
tance cassette fl  anked by two   Frt   sites and the   CSN5/JAB1   exon 2 fl  anked by 
  LoxP   sites. The mouse 129 embryonic stem (ES) cell line (R1) (SV129) was 
electroporated with the construct and subject to G418 selection. Homologous 
recombinants were identifi  ed by Southern blot analysis (SacI digest, 5      probe). 
Two   CSN5/JAB1  fl o x     ES clones were used to derive two independent lines of 
  CSN5  /  JAB1  +/Flox-Neo     mice. The Neo cassette was removed by crossing mice 
with FLPe deleter mice. The CSN5/JAB1    Flox/Flox     mice were further crossed 
with   Lck-Cre   transgenic mice to promote deletion of the CSN5/JAB1 locus in 
T cells (CSN5/JAB1    del/del     mice). The mutant phenotype was analyzed in 129/
C57BL/6 and C57BL/6 genetic backgrounds; no signifi  cant diff  erences were 
observed. All mice were backcrossed at least eight times onto the C57/BL/6J 
background. FLPe deleter mice, Lck transgenic mice (provided by D. Wallach, 
Rehovot, Israel on behalf of Bristol-Myers Squibb), p53       /       mice, Ink4a       /       
mice harboring deletion of exon 2 of the INK4a locus, which inactivates both 
p16  INK4a   and p19  Arf   (purchased from the NCI Mouse Models of Human Can-
cer Consortium) and OTII transgenic mice (imported from The Jackson Lab-
oratory) were used in this study for crossbreeding. Mice were maintained un-
der specifi  c pathogen  –  free conditions and routinely analyzed at 5  –  8 wk after 
birth. All procedures were approved by the local Institutional Animal Care and 
Use Committee and conform to the local regulations and the European Union 
dispositions no. 86 and 609. 
  Genotyping by PCR.     Conventional PCR was performed on a GeneAmp 
2400 machine (PerkinElmer). Primer sequences were as follows: InII1for(p1) 
5     -GGTCAGAAAGCTAGGCCTAAGAAGG-3     , ExII1rev(p2) 5     -GG  C-
AT  GC  ATCACCATTTTCAGTAG-3     , InIIIrev(p3) 5     -GGGCTTAGGA-
ATGCCAAGC-3     . Sequences for   Cre   locus detection were 5     -GCCTG-
CATTACCGGTCGATGCAACGA-3      and rev 5     -GTGGCAGATG-
GCGCGGCA-3     . Primer p1 was used in combination with primer p2 to 
we also observed in both DN and DP cells of CSN5/JAB1-
defi  cient mice, this yielded a complete reversion of the ratio 
between anti- and proapoptotic members of the Bcl-2 family 
of apoptosis regulators. We propose that defective activation 
of NF-     B  –  induced survival programs may partially explain 
the prominent decrease in antiapoptotic Bcl-2 family mem-
bers observed in   CSN5/JAB1  del/del     T cells. This interpretation 
is supported by several fi  ndings in this study, as follows: fi  rst, 
steady-state p65  RelA   nuclear localization is markedly reduced in 
CSN5/JAB1    del/del     DN4 thymocytes compared with WT con-
trols, although further investigation is needed to address the 
underlying mechanisms, as well as the signals leading to induc-
tion of NF-     B that require a functional CSN; second, similar 
to      -catenin, I     B-      is a substrate of the SCF       TrcP   complex, 
which is a CSN-regulated ubiquitin ligase that appears to be 
dysfunctional in   CSN5/JAB1  del/del     mice (  34  ); third, steady-state 
levels of I     B-      are markedly decreased in   CSN5/JAB1  del/del     
thymocytes, both at the mRNA and protein level. This fi  nd-
ing might be a consequence of defective NF-     B activation, 
as I     B-      is a direct NF-     B transcriptional target as part of a 
well-characterized feed-back regulatory loop (  29  ) and is con-
sistent with recent reports linking CSN function to I     B-      
regulation, both in   Drosophila melanogaster   (  42  ) and in mam-
malian cell lines (  43  ). Finally, both Bcl-xL and Bcl-2A1, 
whose levels are strongly reduced in   CSN5/JAB1  del/del     mice, 
have been shown to be directly induced by NF-     B in devel-
oping thymocytes and to play essential roles in overall thy-
mocyte survival and TCR-driven positive selection (  31, 32  ). 
Our fi  nding that transgenic expression of Bcl-xL in bone 
marrow reconstitution experiments rescues the number and 
late developmental stages of   CSN5/JAB1  del/del     thymocytes 
provides further experimental support to our interpretation. 
A large body of evidence supports the notion that NF-     B  –
  induced survival programs are essential in thymic develop-
ment, although it is unclear if thymocytes rely on NF-     B 
prosurvival functions at a particular stage of development 
(  44  ). A prior study based on genetic manipulation of NF-     B 
activation and on the use of a NF-     B activity reporter trans-
gene (  30  ) proposes that transcriptional activity is maximal in 
the fi  nal stage of DN4 cell development, before which high 
Bcl-2 levels replace the antiapoptotic function of NF-     B  –
  induced eff  ectors. Consistent with these fi  ndings, the anti-
apoptotic function of Bcl-2A1 has been shown to be both 
dependent on NF-     B and involved in DN thymocyte sur-
vival (  45  ), whereas Bcl-xL overexpression allows selective 
survival and expansion of DP thymocytes (  46  ). Our fi  ndings 
suggest that defective NF-     B activation may underlie in-
creased apoptosis of both DN and DP cells in   CSN5/JAB1  del/del     
mice, as both subsets display a major reversion of the 
stoichiometric ratio of anti- vs. proapoptotic Bcl-2 family 
members. Possibly, pre-TCR  –  induced activation of NF-     B 
exerts relatively long-lasting eff  ects, which contribute to 
limit death by neglect in DP cells undertaking editing of the 
TCR. Accordingly, defective activation of NF-     B would re-
sult in a large fraction of DP cells dying by apoptosis before 
productive engagement of the TCR. However, our fi  ndings JEM VOL. 205, February 18, 2008 
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was performed for p53, I     B-     , and      -catenin mRNAs using manufacturer-
provided, predesigned primers, probes, and conditions. The following primer 
sets were used for the other transcripts: CSN5/Jab1, 5     -GAAGAAGCTTG-
CATCTTGATTGTGGAGCGAC-3      and 5     -CTCAGGATCCCACA-
CAGCACCTTAGTCTTC-3     ; Bcl-xL, 5     -AGCAACCGGGAGCTGGT-
GGTCGAC-3      and 5     -GACTGAAGAGTGAGCCCAGCAGA-3     ; Bax, 
5     -TCAGCCCATCTTCTTCCAGATGGT-3      and 5     -GATTGCTGAC-
GTGGACACGGACT-3     ;      -actin, 5     -AGGTCCAGACGCAGGATGGC-3      
and 5     -ACTCCTATGTGGGTGACGAG-3     ; Bcl2-A1, 5     -GCATCATTA-
ACTGGGGAAGG-3      and 5     -TCTTCCCAACCTCCATTCTG-3     ; I     B-     , 
5     -CTTGGCTGTGATCACCAACCAG-3      and 5     -CGAAACCAGGT-
CAGGATTCTGC-3     ; p53, 5     -CTTCCCAGCAGGGTGTCACGC-3      and 
5     -GTGCTGTGACTTCTTGTAGATGGC-3     . 
  J     hybridization analysis.     RNA was extracted with TRIzol (Invitro-
gen) from DP/SP cells and reverse transcribed into cDNA. TCR V     s 
transcripts were amplifi  ed for 35 cycles, followed by a nested PCR for 30 
cycles using the same TCR V-specifi  c oligo and internal C      primers. The 
following primers were used: Up mV    3, 5    -ACCCAGACAGAAGGCCT-
GGTCA-3     ; Up mV     14.1, 5     -GTGTCCCTGACAGTCCTGGTT-
GAC-3     ; and Up mV     19, 5     -GCTTCTGACAGAGCTGATCAA-3     ; 
also, respectively, dw mC     -ext, 5     -GCTTTTCTCGGTCAACGTG-
GCACT-3     ; and for the nested PCR Dw mC     -int, 5     -ACTGGGGTAG-
GTGGCGTTGGTCTCT-3     . Amplifi  cation  effi     cacy and uniformity of 
yield were evaluated by agarose gel electrophoresis. For J      hybridization 
analysis, TCR V     -C      PCR products were electrophoresed on 1.5% aga-
rose gel and transferred onto Hybond N  +   nylon membranes (GE Health-
care) using alkaline solution. Hybridizations were performed with      -  32  P 
end  –  labeled, J     -specifi  c oligonucleotide probes; J      oligo sequences and 
hybridization conditions were performed as previously described (  48  ). 
  Immunohistochemical analysis.     In brief, the thymus was rapidly removed 
and stored in 4% formaldehyde/saline solution. 2-mm-thick serial sections 
were obtained and then embedded in paraffi   n. These sections stained with 
hematoxylin and eosin. 4-mm-thick sections were prepared from formalin-
fi  xed, paraffi   n-embedded mouse thymus, deparaffi   nized in xylene, and re-
hydrated in graded alcohol. Immunolocalization for CSN5/JAB1, Bcl-XL, 
CCl3, and Ki67 were performed with quenching of endogenous peroxidase 
in 3% H  2  O  2  , followed by blocking in 5% normal horse serum for 30 min at 
room temperature. The immunoreaction was revealed by horseradish peroxi-
dase (HRP), using 3,3     -diaminobenzidine as chromogen (BioGenex), and 
the slides were slightly counterstained with Harris  ’   hematoxylin. 
  LV production and titration.     Vesicular stomatitis virus  –  pseudotyped LV 
stocks were produced by transient cotransfection of the transfer constructs 
pCCLsin.cPPT.hPGK.eGFP.Wpre or pCCLsin.cPPT.hPGK.BclXL.Wpre 
and pCCLsin.cPPT.hPGK.Bcl-2A1.Wpre, the third-generation packaging con-
structs pMD2.Lg/p and pRSV.Rev, and the pMD2.G envelope con    struct in 
293T cells followed by ultracentrifugation of conditioned medium, as previously 
described (  49  ). Stocks were titered by endpoint expression titer in HeLa cells and 
quantifi  ed for particle content by HIV-1 Gag p24 immunocapture assay. The fol-
lowing primer sets were used to amplify the coding sequences of Bcl-2A1 and BclxL: 
Bcl-2A1 forward 5     -TTTTGGATCCATGTCTGAGTACGAGTTCATG-3      
and reverse 5    -TTTTCTCGAGTTACTTGAGGAGAAAGAGCATTTCC-3     ; 
BclxL forward 5     -TTTTAGATCTATGTCTCAGAGCAACCGGGAGC-3      
and reverse 5     -TTTTCTCGAGTCACTTCCGACTGAAGAGTGCC-3     . 
  Isolation and transduction of hematopoietic progenitors.     6-wk-old 
  CSN5/JAB1  del/del     mice were killed by CO  2   inhalation, and bone marrow was 
harvested by fl  ushing femurs and tibias with PBS-2% FBS (Invitrogen). Lin   –    cells 
were purifi  ed and transduced as previously described (  49  ). 
  Transplantation procedures.     6-wk-old WT female Rag1       /       mice were 
lethally irradiated with 11.5 Gy administered in 2 doses 1 h apart. 2 h after 
irradiation, vector- and mock-transduced cells (7.5   ×   10  5   cells/mouse) were 
identify   fl  oxed   and   wt   alleles and the primer p1 with the primer p3 to assess 
Cre-mediated deletion. 
  Flow cytometry.     Complete medium consisted of RPMI 1640 with Glu-
tamax (Invitrogen) supplemented with 10% FCS (Euroclone), 5.5   ×   10       5   
M 2-ME (Invitrogen), 100 U/ml penicillin, and 100      g/ml streptomycin 
(Invitrogen). Thymi, spleens, LNs (inguinal, cervical, axillary, and brachial), 
and peripheral blood samples were obtained from littermate mice that were 
5  –  6 wk old in most experiments. 5   ×   10  5    –  10  6   dissociated thymocytes were 
suspended in staining buff  er (PBS containing 3% FBS and 0.1% NaN  3  ) for 
15 min on ice for two, three, or four colors and analyzed by a FACScan or 
FACSCalibur fl  ow cytometer (BD Biosciences). For intracellular stainings, 
cells were fi  xed in 2% paraformaldehyde in PBS for 10 min at room tem-
perature and permeabilized with 0.5% saponin in PBS containing 3% FBS. 
The following directly conjugated antibodies (BD Biosciences) were used: 
CD4, CD8, CD3, CD25, CD44, CD69, TCR     , B220, and Bcl2. Data 
analysis was performed with CellQuest software (BD Biosciences). 
  BrdU incorporation assay.     1 mg BrdU was injected i.p., and thymi were 
explanted 1 h after injection. Cell cycle analysis was performed with BrdU-
fl  ow kit (BD Biosciences) according to the manufacturer  ’  s recommenda-
tions. PerCP-labeled CD4 and CD8 were also included with the BrdU-fl  ow 
kit to examine thymocyte subpopulations. 
  Quantitation of apoptosis by Annexin V staining.     Thymocytes were 
incubated in RPMI complete medium at a concentration of 2.5   ×   10  6   
cells/ml in 12-well plates. Cells were analyzed either directly after isolation 
(time 0) or after incubation for the indicated time points. Cells were washed 
and stained using the Annexin V-FITC Apoptosis Detection kit (Bender 
MedSystems) with propidium iodide (PI) to stain dead cells, according to 
the manufacturer  ’  s recommendations. PerCP-labeled CD4 and CD8 were 
also included with the AnnexinV-FITC kit to examine thymocyte sub-
populations. Apoptotic rate was assessed on cells gated as   “  viable  ”   based on 
physical parameters (forward and side scatter), by scoring events consisting 
of early (AnnexinV-FITC  +  , PI        ) and late (AnnexinV-FITC  +  , PI  +  ) cells. 
  Immunoblotting.     Cells were washed in PBS and lysed in RIPA buff  er. 
Protein extracts (30      g each) were resolved by 8  –  10% sodium dodecyl sul-
fate-PAGE and transferred to nitrocellulose membranes (Hybond C Extra; 
GE Healthcare) in a blotting apparatus. Antibodies to p53 (Cell Signaling 
Technology), p27 (BD Biosciences), CSN5/JAB1 (Sigma-Aldrich), Cre 
(Covance),      -catenin (BD Biosciences), actin (Sigma-Aldrich), glycocorti-
coid receptor (Santa Cruz Biotechnology), Cdt1 (Santa Cruz Biotechnol-
ogy), monocyte-derived macrophage 2 (Santa Cruz Biotechnology), p65  RelA   
(Santa Cruz Biotechnology), I     B      (Cell Signaling Technology), Cul1 
(Zymed Laboratories), and CycD3 (Santa Cruz Biotechnology) were used 
for immunoblot analysis. To obtain purifi  ed thymocyte subsets, cell suspen-
sions were treated with anti-CD4 and -CD8 antibodies, followed by incuba-
tion with anti  –  rat IgG-conjugated magnetic beads, to recover DP/SP thy-
mocytes (positive isolation). Nonadherent cells were subject to a second 
round of negative isolation by treatment with anti-CD4, -CD8, -B220, and 
-CD25 antibodies to recover DN1/DN4 thymocytes. Purity of the obtained 
DN1/DN4 and DP/SP subsets was assessed by fl  ow cytometry and typically 
exceeded 90% (unpublished data). NF-     B activation assays and subcellular 
fractionations were performed as previously described ( 47  ). NF-    B immuno-
blotting was performed according to the manufacturer  ’  s instructions. 
  RT-PCR analysis.     Total RNA was extracted from sorted thymocytes by 
RNeasy Micro kit (QIAGEN) according to the manufacturer  ’  s recommen-
dations, and the RNA was reverse transcribed with M-MLV (Promega) using 
random hexamers following the instructions of the manufacturer. Each sam-
ple was normalized by PCR for      -actin mRNA content. For semiquantita-
tive RT-PCR analysis, serially diluted cDNA was amplifi  ed as follows: 94  °  C 
for 1 min, followed by 28  –  30 cycles of 94  °  C for 1 min, 60  °  C for 1 min, and 
72  °  C for 2 min. Quantitative RT-PCR by Taqman (Applied Biosystems) 476 CSN DEFICIENCY IMPAIRS T CELL DEVELOPMENT | Panattoni et al.
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injected via the tail vein. The bone marrow chimeras are used 6 wk after the 
transplant to allow complete reconstitution of immune system. 
  Online supplemental material.     Fig. S1 illustrates the strategy to conditionally 
delete the CSN5/JAB1 locus. Fig. S2 shows T cell subset distribution in periph-
eral lymphoid organs. Fig. S3 show normal patterns of TCR gene rearrangements 
in   CSN5/JAB1  del/del     thymocytes. Fig. S4 shows intracellular and surface TCR 
expression in   CSN5/JAB1  del/del     thymocytes; Fig. S5 shows incomplete pene-
trance of thymic phenotype in   CSN5/JAB1  del/del     mice. Table S1 shows T cell 
counts in  CSN5/JAB1  del/del     mice crossed onto the OT-II transgenic background. 
Table S2 shows the relative amounts of mRNAs coding for p53, I     B     , and 
     -catenin in   CSN5/JAB1  del/del     thymocytes. The online version of this article is 
available at http://www.jem.org/cgi/content/full/jem.20070725/DC1. 
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